Viewing data from:

DOXEPIN HYDROCHLORIDE

ANDA

DOXEPIN HYDROCHLORIDE | A210675 | EPIC PHARMA LLC

5 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 11 NDCs

Highest NADAC/Unit

$0.2669

per ea

Lowest NADAC/Unit

$0.0776

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
24658079705DOXEPIN 100 MG CAPSULE	$0.2669	EA	Generic	—	2026-08-19
24658079701DOXEPIN 100 MG CAPSULE	$0.2669	EA	Generic	—	2026-08-19
24658079710DOXEPIN 100 MG CAPSULE	$0.2669	EA	Generic	—	2026-08-19
24658079610DOXEPIN 75 MG CAPSULE	$0.1827	EA	Generic	—	2026-08-19
24658079601DOXEPIN 75 MG CAPSULE	$0.1827	EA	Generic	—	2026-08-19
24658079510DOXEPIN 50 MG CAPSULE	$0.1535	EA	Generic	—	2026-08-19

Showing 6 of 11 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs2 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

OLON SPADOXEPIN HYDROCHLORIDE

DMF 50251983

MSN LIFE SCIENCES PRIVATE LTDDOXEPIN HYDROCHLORIDE USP

DMF 335592019

R L FINE CHEM PVT LTDDOXEPIN HYDROCHLORIDE

DMF 344382020

RAKS PHARMA PVT LTDDOXEPIN HYDROCHLORIDE USP

DMF 350172020

BOEHRINGER MANNHEIM GMBHInactiveDOXEPIN

DMF 24101975

GANES CHEMICALS INC PENNSVILLE DIVInactiveDOXEPIN HYDROCHLORIDE

DMF 68561987

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (5)

Sort:

#001 — EQ 10MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Oct 16, 2020

No patent or exclusivity listings for this strength.

#002 — EQ 25MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Oct 16, 2020

#003 — EQ 100MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Oct 16, 2020

#004 — EQ 50MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 3, 2022

#005 — EQ 75MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 3, 2022